Clinical Trial Update: Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma [Phase 3]

View source ↗

Summary

This document reports a Phase 3 trial update on using levofloxacin to prevent chemotherapy-related infection in patients with solid tumors or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Breast Cancer
• Extragonadal Germ Cell Tumor
• Lung Cancer
• Lymphoma
• Ovarian Cancer
• Small Intestine Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Levaquin (levofloxacin)

Snippet

Sponsor: Cancer Research Campaign Clinical Trials Centre | Conditions: Brain and Central Nervous System Tumors, Breast Cancer | Phase 3 | Status: COMPLETED